Stock markets face a big test as covid vaccine results likely from next month
Late-stage data on trials of covid vaccines by companies such as Pfizer Inc and Moderna Inc possible as soon as October or November
Optimism that vaccines are on the way to end the coronavirus pandemic has been a major factor in this year’s U.S. stock resurgence. That will face a critical test in coming weeks, as investors await clinical data on whether they actually work.
Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!Let’s get started